Zevra Therapeutics
ZVRA
ZVRA
60 hedge funds and large institutions have $33.8M invested in Zevra Therapeutics in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 26 increasing their positions, 8 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
64% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 14
92% less capital invested
Capital invested by funds: $404M → $33.8M (-$370M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
60
Holding in Top 10
–
Calls
$2.32M
Puts
$2.51M
Top Buyers
| 1 | +$1.91M | |
| 2 | +$841K | |
| 3 | +$388K | |
| 4 |
Millennium Management
New York
|
+$350K |
| 5 |
Morgan Stanley
New York
|
+$207K |
Top Sellers
| 1 | -$427K | |
| 2 | -$321K | |
| 3 | -$152K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$143K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$139K |